Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The initial decrease in effective peritoneal surface area is not caused by an increase in hematocrit

D G Struijk1, R T Krediet, G C Koomen

  • 1Department of Medicine, Academic Medical Center, Amsterdam, The Netherlands.

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Longitudinal Membrane Function in Peritoneal Dialysis Patients According to Dialysis Fluid Biocompatibility.

Kidney international reports·2020
Same author

Management of encapsulating peritoneal sclerosis: a guideline on optimal and uniform treatment.

The Netherlands journal of medicine·2011
Same author

Predialytic period and baseline peritoneal membrane status: any connection?

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2010
Same author

Prevalence of anemia and its impact on mortality and hospitalization rate in predialysis patients.

Nephron. Clinical practice·2010
Same author

Effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in patients with chronic kidney disease.

The Netherlands journal of medicine·2010
Same author

The Dutch EPS Registry: increasing the knowledge of encapsulating peritoneal sclerosis.

The Netherlands journal of medicine·2009
Same journal

Translational insights into extracellular vesicles in peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

Quercetin attenuates peritoneal fibrosis by upregulating ferroptosis-related glutathione peroxidase 4 (GPX4) and solute carrier family 7 member 11 (SLC7A11) in MeT-5A and rat models: Supported by clinical mRNA expression data.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

An in vitro comparison of bacterial touch contamination prevention between a novel APD cycler connector and existing APD connectors.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

What is the effect of the assistance on the risk of transfer to HD after an unplanned peritoneal dialysis initiation? A cohort study with data from the RDPLF.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

2026 ISPD Position Statement on tracking and reporting loss from PD therapy.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same journal

Important factors in the choice of dialysis modality among Japanese patients initiating peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
See all related articles

Hemoglobin and hematocrit levels increased in patients starting continuous ambulatory peritoneal dialysis (CAPD). However, these changes did not correlate with altered peritoneal membrane transport function during early CAPD treatment.

Area of Science:

  • Nephrology
  • Clinical Medicine
  • Physiology

Background:

  • Peritoneal dialysis is a key treatment for end-stage renal disease.
  • Understanding early changes in peritoneal membrane function is crucial for optimizing treatment.
  • Hemoglobin and hematocrit levels can fluctuate during dialysis treatment.

Purpose of the Study:

  • To investigate the relationship between initial changes in peritoneal membrane transport and hemoglobin/hematocrit levels in continuous ambulatory peritoneal dialysis (CAPD) patients.
  • To analyze how peritoneal solute and fluid transport kinetics evolve within the first 7 months of CAPD.

Main Methods:

  • Prospective longitudinal study involving 34 CAPD patients.
  • Two assessments: within 3 months and 4 months after starting CAPD.

Related Experiment Videos

  • Calculated mass transfer coefficients (MTC) for solutes and net fluid removal over a 4-hour dwell with 1.36% glucose.

    • Main Results:

    • Peritoneal membrane transport (urea, lactate, creatinine, glucose MTC) was higher in the first examination compared to the second.
    • Net fluid removal was significantly lower during the initial examination.
    • Hemoglobin and hematocrit levels increased significantly between the two examinations.
    • No correlation was found between changes in Hb/Ht and changes in solute/fluid transport.

    Conclusions:

    • Increased hemoglobin and hematocrit levels in early CAPD do not explain the observed changes in peritoneal transport kinetics.
    • Altered peritoneal transport during the initial months of CAPD is likely due to the recent initiation of treatment.
    • Potential causative factors include increased peritoneal surface area or local irritation from dialysate.